21.04.2011 • News

Call for Nominees for 2011 HART Plant of the Year Award

HART Communication Foundation is seeking qualified nominees for the 10th annual HART Plant of the Year Award. End users and manufacturers from all world areas are encouraged to enter their plant or customer's plant for recognition. The HART Plant of the Year is the only international award presented to end user companies in the process automation industry to recognize the exceptional application of HART Communication technology. Nominations will be accepted through 30 June 2011.

"Selection of the HART Plant of the Year is based on a plant's use of HART Communication not on the size of the installation. We are seeking a plant that has taken the capabilities of HART instruments beyond configuration and calibration," says Ron Helson, HART Communication Foundation Executive Director. "Or, the plant that is using real-time diagnostics and process variables in HART-enabled devices integrated with control, information, asset management, or safety systems."

Previous recipients include MOL Danube (Hungary), Mitsubishi Chemical (Japan), PDVSA Petropiar (Venezuela), StatoilHydro (Norway), Sasol Solvents (South Africa), Clariant (Germany), and DuPont (USA).

The HART Communication Foundation is an independent, not-for-profit membership organization that provides global support for the application of HART technology. The Foundation is the technology owner, standards setting body and central authority on the HART Communication Protocol, establishing and controlling new technology developments and enhancements that support the needs of the process automation industry. Founded in 1993, Foundation membership includes more than 240 companies worldwide.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read